Pharmacy Practice and Saudi Regulations Flashcards

A hospital pharmacist receives a medication order that appears to be an unusual dose. What is the correct action according to Saudi hospital pharmacy standards?

Answer: Clarify the order with the prescriber before dispensing — document the clarification

Pharmacists have a professional and legal duty to clarify ambiguous, unusual, or potentially unsafe medication orders before dispensing. This is a fundamental aspect of the pharmacist's role as a patient safety safeguard in the medication use process. The clarification must be documented.

The Joint Commission on Accreditation (JCIA/CBAHI) requires hospitals to have a pharmacy and therapeutics (P&T) committee. What is the primary role of the P&T committee?

Answer: Manage the hospital formulary — evaluating and approving drugs for use, establishing medication use policies, and overseeing medication safety programs

The Pharmacy and Therapeutics (P&T) Committee is a multidisciplinary body (physicians, pharmacists, nurses) responsible for: formulary management (drug selection, addition, removal), medication use policies, drug utilization reviews, pharmacovigilance oversight, and medication safety programs (LASA, high-alert medications).

A pharmacist is labeling a medication for dispensing in a Saudi hospital. Which information is mandatory on the medication label?

Answer: Patient name, drug name, dose, route, frequency, dispensing date, pharmacist name, and expiry date

Saudi GDP and accreditation standards require dispensed medications to be labeled with: patient name and ID, drug generic and brand name, dose, route of administration, frequency, dispensing date, pharmacist's name and signature, expiry date, and storage requirements. Complete labeling prevents medication administration errors.

A pharmacist discovers that a batch of medications has been recalled by the SFDA due to contamination. What is the required action?

Answer: Remove all affected stock immediately, quarantine it, notify relevant departments, and return to supplier per recall instructions

SFDA drug recalls require immediate action: remove affected products from all storage areas, quarantine them, notify all relevant clinical areas, document removed quantities, and return to supplier or manufacturer as instructed. Using recalled products after notification is a serious regulatory violation.

Under Saudi SFDA regulations, what is the shelf-life requirement for medications before they can be dispensed?

Answer: A minimum of 25% of remaining shelf life (or at least 6 months in most guidelines) at the time of dispensing

Saudi pharmacy practice guidelines require that medications have adequate remaining shelf life at the time of dispensing — typically at least 25% of original shelf life or 6 months minimum. Dispensing medications near expiry (especially to patients requiring long-term therapy) is considered substandard practice.

A pharmacist in Saudi Arabia is asked about biosimilar substitution. Under current SFDA guidelines, can pharmacists substitute a reference biologic with a biosimilar?

Answer: Only if the SFDA has designated the biosimilar as interchangeable and substitution is permitted by the prescriber or institutional policy

Biosimilars are not automatically interchangeable with reference biologics (unlike small-molecule generics) due to structural complexity and immunogenicity concerns. SFDA regulates biosimilar designation. Substitution requires SFDA interchangeability designation and, in most institutional policies, prescriber approval or notification.